Search Results 341-350 of 37969 for Two-phase
PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose ... Two escalating dose (low dose and high dose) cohorts are planned. The duration ...
Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
This is a Phase 2, multicenter, open-label, 2-part, single-arm, 2-stage study of tazemetostat 800 mg two times a day (BID) administered orally. Screening of ...
This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics ...
A change in roles or life events, such as a job loss or a child leaving home. 2. Become aware of thoughts and beliefs. Once you've learned which situations ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
... phase 2 portion of the trial. This trial is exploring the use of a new drug ... This will be given along with 2 with two other drugs, lenalidomide and daratumumab ...
Participate in an observational study arm that receives SoC (i.e., two-stage prosthetic joint replacement) and. i. Sonication of the explanted prosthesis and ...
This is a Phase 2, multicenter, open-label study to evaluate the efficacy ... The purpose of this study is to compare two red blood cell transfusion ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.